Not Cleared Direct

DEN230008 - DermaSensor (FDA 510(k) Clearance)

Jan 2024
Decision
344d
Days
Class 2
Risk

DEN230008 is an FDA 510(k) submission for the DermaSensor. This device is classified as a Software-aided Adjunctive Diagnostic Device For Use By Physicians On Lesions Suspicious For Skin Cancer (Class II - Special Controls, product code QZS).

Submitted by Dermasensor, Inc. (Miami, US). The FDA issued a Not Cleared (DENG) decision on January 12, 2024.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.1830. A Software-aided Adjunctive Diagnostic Device For Use By Physicians On Lesions Suspicious For Skin Cancer Is A Prescription Device That Uses A Software Algorithm To Analyze Optical Or Other Physical Properties Of A Skin Lesion And Returns A Classification Of The Skin Lesion. The Device Is Intended For Use By A Physician Not Trained In The Clinical Diagnosis And Management Of Skin Cancer As An Adjunctive Second-read Device Following Identification Of A Suspicious Skin Lesion. It Is Not For Use As A Standalone Diagnostic And Is Not For Use To Confirm A Clinical Diagnosis..

Submission Details

510(k) Number DEN230008 FDA.gov
FDA Decision Not Cleared Not Substantially Equivalent (DENG)
Date Received February 02, 2023
Decision Date January 12, 2024
Days to Decision 344 days
Submission Type Direct
Review Panel General & Plastic Surgery (SU)
Summary -

Device Classification

Product Code QZS - Software-aided Adjunctive Diagnostic Device For Use By Physicians On Lesions Suspicious For Skin Cancer
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.1830
Definition A Software-aided Adjunctive Diagnostic Device For Use By Physicians On Lesions Suspicious For Skin Cancer Is A Prescription Device That Uses A Software Algorithm To Analyze Optical Or Other Physical Properties Of A Skin Lesion And Returns A Classification Of The Skin Lesion. The Device Is Intended For Use By A Physician Not Trained In The Clinical Diagnosis And Management Of Skin Cancer As An Adjunctive Second-read Device Following Identification Of A Suspicious Skin Lesion. It Is Not For Use As A Standalone Diagnostic And Is Not For Use To Confirm A Clinical Diagnosis.